<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166596">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02036398</url>
  </required_header>
  <id_info>
    <org_study_id>RMC-6405</org_study_id>
    <nct_id>NCT02036398</nct_id>
  </id_info>
  <brief_title>Tubeless Versus Standard Upper Pole Percutaneous Nephrolithotomy</brief_title>
  <official_title>Comparison of Complications Between Patients Undergoing Standard Percutaneous Nephrolithotomy With Nephrostomy Tube Placement and Tubeless Percutaneous Nephrolithotomy With Double J Stent Only Placement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of complications between standard upper pole percutaneous nephrolithotomy (PCNL)
      with nephrostomy placement and double J stent and PCNL with double J placement only without
      nephrostomy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Number of Participants with pleural effusion</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Assessment and comparison of pleural effusion incidence between patients in both groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score on visual analog scale</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessment and comparison of pain by a visual analog scale between patients in both groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Pleural Effusion</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Nephrostomy tube + double J stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard therapy group with nephrostomy tube and double J stent left at the end of the PCNL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Double J stent  without nephrostomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Double J stent only left at the end of the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Double J stent  without nephrostomy</intervention_name>
    <description>Double J stent only left at the end of the procedure without placement of a nephrostomy tube</description>
    <arm_group_label>Nephrostomy tube + double J stent</arm_group_label>
    <arm_group_label>Double J stent  without nephrostomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nephrostomy tube</intervention_name>
    <arm_group_label>Nephrostomy tube + double J stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing upper pole percutaneous nephrolithotomy older than 18 years of
             age and willing to participate

        Exclusion Criteria:

          -  Patients younger than 18 years of age

          -  Patients unwilling to participate in the study

          -  Patients that nephrostomy tube placement was a preequisite at the end of the
             procedure
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanan Goldberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rabin Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hanan Goldberg, MD</last_name>
    <phone>972544315412</phone>
    <email>gohanan@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Urology department, Rabin Medical Center</name>
      <address>
        <city>Petach Tiqva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanan Goldberg, MD</last_name>
      <phone>972544315412</phone>
      <email>gohanan@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Hanan Goldberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 14, 2014</lastchanged_date>
  <firstreceived_date>January 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rabin Medical Center</investigator_affiliation>
    <investigator_full_name>Hanan Goldberg</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Percutaneous Nephrolithotomy (PCNL)</keyword>
  <keyword>Nephrostomy</keyword>
  <keyword>Double J stent</keyword>
  <keyword>PleuraL Effusion</keyword>
  <keyword>Pain</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pleural Effusion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
